Earnings
Alkermes Stops Reporting Avadel's Profit After Its $2.3 Billion Deal, Calling It Impracticable
The drugmaker's latest quarterly report says Avadel's stand-alone net income can no longer be presented, while LUMRYZ sales reached $226.0 million.